Close
Nordic 9Nordic 9

OxThera (private company)

Sweden oxthera.com
See something wrong or missing? Let us know
Offices:Stockholm
Industry:BiotechPharma
Business model:B2B

OxThera is a biopharmaceutical company with products in late stage clinical development focusing on Primary and Secondary Hyperoxaluria.

OxThera’s intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria, and enzymes. Oxabact® holds Orphan Drug designations in Europe and in the US for the treatment of primary hyperoxaluria.

Investors: we tracked 9 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 83.05M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to OxThera

Name Criteria
Denmark NMD Pharma
57%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Spain Sanifit Therapeutics
57%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 5
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Denmark Cytoki Pharma
57%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom Causaly
57%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom ReViral
53%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Denmark STipe Therapeutics
53%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Denmark AFYX Therapeutics
52%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 10M+ USD
Netherlands Citryll
52%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 10M+ USD
Finland Desentum
52%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 1
Sweden Cinclus Pharma
50%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Top